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Abstract 
Nanogels are submicron-size aqueous dispersions of water-swollen particles, composed of nano-sized 
three-dimensional highly cross-linked networks of hydrophilic polymers. An active pharmaceutical agent or 
therapeutic agent with high or low molecular weight can be easily encapsulated into nanogels that can be 
delivered to the site of action via various routes, including oral, pulmonary, nasal, parenteral and 
intraocular routes, among others. Therapeutic agents encapsulated into nanogels improve the therapeutic 
activity in the biological environment. The application of different nanogels in drug delivery and recent 
clinical trial studies has been described concisely in this review. 
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Introduction  
Nanogels are commonly used in sensing, diagnostics, and bioengineering, but they are also often used in 
drug delivery [1,2]. Nanogels have benefits over conventional and macro-sized delivery systems because of 
their higher drug loading capacity, high stability, and improved contact time with the skin surface, which 
makes it more convenient as a transdermal drug delivery system. Water-soluble non-ionic polymers like 
hydroxylpropyl methylcellulose as well as ethylcellulose are commonly used to stabilise nanogel dispersions 
[3-7]. Phase separation of drug-loaded nanogels could occur due to interactions (electrostatic, hydrophobic, 
van der Waals) between the polymeric matrix and the active agent, which could be prevented by dispersing 
hydrophilic polymers. The dispersed hydrophilic polymer becomes exposed to the skin surface by forming a 
protective layer around the nanogel, allowing drug particles to remain dispersed in the gel matrix [8-10]. 
Modified natural biopolymers possess a high degree of functional groups with additional functional cross-
linkers used for the formulation of biopolymer-based nanogels. Innovative techniques such as 
photopolymerisation, chemical cross-linking, click chemistry-based cross-linking etc., are used to derive the 
self-assembly and cross-linking of hydrophilic block copolymers. Between internal and external layers of 
nanogels, block polymers permit the control of drug release from a polymer matrix [11-13]. For target-
specific or cell-specific drug delivery, nanogels are modified with ligands to permit receptor-
mediated drug release at the site of action [14-15]. Drug- or biologically-loaded nanogels cross biological 
barriers and release the therapeutic agent inside cells [16-18]. In recent years, nanogels were effectively 
utilised in the field of biotechnology to deal with genetics, enzyme immobilisation and protein synthesis, 
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thus providing an efficient tool to cater for novel therapeutic systems in medicine (Table 1). A novel core-
shell magnetic nanogel was prepared using poly(acrylamide) for cancer therapy. Pluronic 
poly(ethyleneimine) was used to prepare a thermoresponsive nanogel for the transdermal delivery of an 
active agent. Nanogel-based drug delivery formulations increase the effectiveness and safety of certain 
anti-cancer drugs as well as many other drugs due to their chemical composition, which has been 
confirmed by in vivo studies in animal models. Nanogels are a favourable and innovative drug delivery 
system that can play a vital role by addressing the problems associated with old and modern therapeutics 
such as nonspecific effects and poor stability [19-23]. 
Table 1. Applications and types of nanogel in drug delivery [21-23] 




Minimal phototoxicity of pheophorbide 
Cross-linked branched network 
of poly(ethyleneimine) and PEG 
Polyplex nanogel 
Elevated activity and reduced cytotoxicity 
of fludarabine 
Acetylated chondroitin sulphate Self-organising nanogel Doxorubicin loaded 










Hyperthermia cancer treatment and 
targeted drug delivery 
Poly(acrylamide) 
Novel core shell magnetic 
nanogel 
Radiopharmaceutical carrier for cancer 
radiotherapy 
Methylacrylic acid and N,N’-
methylene-bis-(acrylamide) 
Supermagnetic nanogel 
functionalised with carboxyl 
group 
α-chymotrypsin immobilized on aminated 
nanogel 









Suicide gene hTERT –CD-TK delivered for 
lung cancer 
Acylate group modified 
cholesterol bearing pullulan 
Cross-linked raspberry-like 
assembly nanogel 




In situ gelatinised thermo-
sensitive nanogel 
Drug loading capacity, bovine serum 
albumin 
Glycol chitosan grafted with 3-
diethylaminopropyl groups 
pH-responsive Doxorubicin uptake accelerated 
Acetylated hylauronic acid Specific targeting nanogel Doxorubicin loaded nanogel 
Pluronic poly(ethyleneimine) 
Temperature responsive and 
volume transition nanogels 
Thermo responsive endosomal rupture by 
nanogel and drug release 
Methods used for the preparation of nanogels  
I) Preparation of nanogel using polymeric precursors  
II) Synthesis of nanogel network by heterogeneous polymerisation of monomers  
Polymers and monomers having different nanoscopic structures formed by amphiphilic copolymers are 
used for the preparation of nanogels. Amphiphilic copolymers are able to self-assemble in solution, hence 
they form nanogels [24-25].  
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I) Preparation of nanogels from polymeric precursors  
Disulphide-based cross-linking  
Disulphide linkages were prepared by inverse mini-emulsion atom transfer radical polymerisation 
(ATRP). In this process, water-soluble monomer oligo(ethylene glycol) monomethyl ether methacrylate 
(OEOMA) with different molecular weights were cross-linked in the ATRP reaction with the disulphide-
functionalised cross-linker. The nanogels formed are considered to have a uniformly cross-linked network, 
which is supposed to improve aqueous solubility and control the release of encapsulated agents; the 
nanogels are shown to be biodegradable into water-soluble polymers in the presence of a biocompatible 
glutathione tripeptide which is commonly found in cells. The biodegradation of nanogels could trigger the 
release of drugs from the nanogels. Amphiphilic random copolymers are used to prepare a nanogel system 
by self-cross-linking [26-27]. A nanosized product in aqueous solution is formed by hydrophilic 
poly(ethylene glycol) and pyridyl disulphide. Thiol disulfide exchange reaction is depending primarily on the 
concentration of thiol exchangers like dithiothreitol (DTT). The size of the nanogel would be reduced by 
using cross-linking monomer or polymer chains. A lower critical solution temperature (LCST) of polymers 
also affects the size of the nanogel. Lipoic acid-encapsulated dextran was prepared by thiol-exchange using 
the same method. A catalytic amount of DTT freely cross-linked with doxorubicin was synthesised from the 
assembly of the polymer [28-29]. 
Poly(ε-caprolactone) (PCL) and hydrophilic poly(ethylethylenephosphate) (PEEP) were used as drug 
carriers for the development of a micellar nanoparticle system for intracellular drug release which is 
triggered by glutathione in tumour cells. Tang et al. synthesised a disulphide-linked di-block copolymer of 
PCL and PEEP (PCL-SS-PEEP), which forms biocompatible micelles in aqueous solution and detaches the 
shell material under glutathione stimulus, resulting in rapid drug release with the destruction of the 
micellar structure shown in Figure 1 [30]. 
 
Figure 1. Synthesis pathway of the disulphide-linked PCL-SS-PEEP and schematic illustration of intracellular 
drug release (reprinted with the permission from [30]. Copyright (2016) American Chemical Society). 
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Amine group is more common in amine-based cross-linked nanogel development because the amine 
group has higher reactivity against carboxylic acids, isocyanates, and iodides. Cross-linked knedel-
resembling structures using amine cross-linkers were prepared by the Wooley group. Hydrophilic, 
amphiphilic di-block copolymers were prepared by reversible addition fragmentation chain transfer 
polymerisation. Amidation of carboxyl group-containing self-assembled block copolymers with a diamine 
cross-linking agent leads to the cross-linking of micellar assemblies; the remaining carboxylic group was 
altered for orthogonal surface modifications in the form of other functional moieties to form a cross-linked 
nanogel. Furthermore, reaction with isocyanate carriers is an alternative cross-linking approach to prepare 
nanogels. pH-responsive cross-linked micelles were prepared by the addition of 1,8-diaminooctane to a 
micellar combination of 3-isopropenyl-α,α-dimethyl benzyl isocyanate bearing copolymers [31-32].  
We prepared poly(acrylic acid) (PAA) and sodium carboxymethylcellulose (NaCMC)-based luliconazole 
loaded nanogels. Luliconazole was encapsulated in PAA and Na-CMC by free radical polymerisation. 
Luliconazole is an azole antifungal that works by preventing the growth of the fungus [33] and is used to 
treat skin infections such as athlete's foot, jock itch, and ringworm. Figure 2 shows particle size analysis for 
the optimised nanogel containing luliconazole. The average particle size of nanogel was 259 nm at the 
count rate of 360 kcps with polydispersity index (PDI) of 0.2 showed narrow particle size distribution. 
 
Figure 2. Average particle size of luli-
conazole loaded poly(acrylic acid) nanogel 
 
The formation of nanogel (NaCMC-g-PAA) from NaCMC and acrylic acid/sodium acrylate in the presence 
of N,N’-methylene bisacrylamide (MBA) was carried out using potassium persulphate as a free radical 
initiator [34-35]. Figure 3 shows the FESEM micrograph of the optimised nanogel formulation. From the 
figure, it can be observed that the formed nanogel is spherical in nature. 
Click chemistry-based cross-linking  
This method is discovered by Wooley and Hawker group for the synthesis of nanogels [36]. In this 
method, alkynyl groups were restrained to the corona of assembled micelles prepared from amphiphilic di-
block copolymers of poly(acrylic acid)-b-polystyrene via the amidation of acrylic acid groups. Azido 
dendrimers and micelles are generally prepared by click reactions. Covalently cross-linked micelles are 
entrapped into the nanogel assemblies. Cross-linked polyion nanogel micelles were prepared by Liu et al. 
using a click chemistry approach. Core cross-linked polyion complex micelles had thermosensitive coronas 
with high stability against salt and pH [36-37]. 
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Figure 3. FESEM image of luliconazole loaded poly(acrylic acid) nanogel 
Thermoresponsive poly(N-isopropylacrylamide) (PNIPAM) represents an attractive candidate to 
introduce physical cross-linking via the association of hydrophobic domains because it has a gelling 
temperature below body temperature and good biocompatibility. PNIPAM is a non-biodegradable, thermo-
reversible hyaluronan-poly (N-isopropylacrylamide) (HA-PNIPAM) hydrogel with a well-defined molecular 
architecture and properties; this hydrogel can be synthesised through reversible addition fragmentation 
chain transfer (RAFT) polymerisation and “click” chemistry polymerisation method [38]. 
 
The effect of PNIPAM grafting length and density on HA-PNIPAM properties was evaluated by methods 
relevant for cell therapy. It was found that the reversibility of the PNIPAM gelling process was improved in 
the presence of HA. The efficiency of the “click” reaction facilitates the control of the DS of PNIPAM chains. 
RAFT polymerisation allows the preparation of PNIPAM of controlled molecular weight and low PDI. This 
control of the critical parameters of PNIPAM molecular weight and grafting density allowed the gel to be 
Figure 4. N-(3-dimethylaminopropyl)-N-ethylcarbo-
diimide hydrochloride (EDC), N-hydroxy-succin-
imide (NHS) synthesis of hyaluronanpropargyl-
amide (hapa), followed by copper-catalysed azide-
alkyne cycloaddition of hapa with azido-terminated 
poly(N-isopropylacrylamide) N3-PNIPAM (reprinted 
with the permission from [38]. Copyright (2010) 
American Chemical Society). 
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optimised for regenerative medicinal applications. The two synthetic steps of HA-PNIPAM are shown in 
Figure 4. The EDC/NHS mediated coupling of PPA to carboxylic acid groups on the hyaluronan salt and the 
copper-catalysed azide-alkyne cycloaddition of the N3-PNIPAM to the hyaluronan-propargylamide [38-40]. 
Photo-induced cross-linking  
This is an alternative method for nanogel preparations. In this method, the polymer chain is stabilised 
using cross-linking and is functionalised with dimerisable or polymerisable units. Double hydrophilic block 
copolymers can be encapsulated into the coumarin dimer. Coumarin dimers, when cured with UV 
light >310 nm, are assembled into micelles and then photo-cross-linked to form nanogels (Figure 5). 
 
Figure 5. Scheme for UV photopolymerisation 
This nanogel shows interaction between lower critical solution temperature (LCST) and upper critical 
solution temperature (UCST) behaviours. UCST is the critical temperature above which the contents of a 
mixture are miscible. The light penetrating capability has been incorporated into dendrimer structures 
to increase drug release in response to light stimulation. Dendrimers of coumarin act as alternative cross-
linkers to control the accessibility of substrate in the nanogel networks. When the solution of coumarin was 
cured in UV light, the ester groups were confined in the interior assembly of nanogel. Enzymatic 
degradation of the substrate was very much inhibited. Curing the cross-linked assembly by UV light 
improves the enzymatic action due to the de-cross-linking of the coumarin dimer, which exposes the 
substrate to enzymes [41-43]. A stimuli-responsive nanogel prepared in water by a core cross-linking 
technique using diblock copolymer micelles by photo-cross-linking of the micelle core [44]. The preparation 
of poly(ethylene glycol)-b-poly(2-(diethylamino) ethyl methacrylate-co-2-cinnamoyloxyethyl acrylate) (PEG-
b-P(DEAEMA/CEA)), a pH-responsive block copolymer, by reversible addition-fragmentation chain transfer 
(RAFT)-controlled radical polymerisation using poly(ethylene glycol)-based chain transfer agent (PEG-CTA). 
The poly(ethylene glycol) (PEG) block in PEG-b-P(DEAEMA/CEA) is soluble in water, independent of pH, 
while the solubility of DEAEMA depends on pH (Figure 6) [44-45]. 
We have formulated poly(acrylamide) (PAA) nanogel using UV polymerisation. PAA gels are mainly 
polymerised using catalysts such as tetramethylenediamine (TEMED) and ammonium persulphate (APS), 
which are highly toxic and lead to slow polymerisation, which is time-consuming and takes 45 min to 1 h for 
lower gel precursor concentrations. Photo-crosslinking with various photoinitiators, such as Irgacure 2959, 
has been more recently used for the synthesis of PAA hydrogels with a stiffness gradient and used for the 
quick preparation of large PAA hydrogel arrays for applications such as drug screening. Photo-crosslinking 
circumvent the use of toxic catalysts and is characteristically much faster than chemical cross-linking 
method. Final properties of UV-polymerized gels are depending on the UV wavelength, consistency, light 
intensity, and interaction time [46]. Figure 7 shows the average particle size of thymol loaded PAA nanogel 
and Figure 8 shows the FESEM micrograph of thymol loaded PAA. It is clear from the figure that the nanogel 
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prepared by UV-polymerisation is spherical in nature. 
 
Figure 6. Synthetic route for poly (ethylene glycol)-b-poly(2-(diethylamino) ethyl methacrylate-co-2-
cinnamoyloxyethyl acrylate) (reprinted with permission from [45]. Copyright (2009) American Chemical 
Society).                                                                                                                                                                                                                                                      
 
Figure 7. Average particle size of thymol 
loaded polyacrylamide nanogel prepared 
by photopolymerisation 
 
Physical cross-linking  
Physically cross-linked gels are also known as pseudo gels which have weaker van der Waals linkages, 
hydrogen bonding, hydrophobic or electrostatic interactions that are involved in the synthesis of pseudo 
gels. The physicochemical properties of gels depend on properties of the polymer, temperature, ionic 
strength, concentration of polymer and the cross-linking agent. Combination of amphiphilic block 
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Figure 8. FESEM image of thymol loaded poly(acrylamide) acid nanogel prepared by photopolymerisation 
II) Synthesis of nanogel networks by heterogeneous polymerisation of monomers 
Bi-functional monomers are chemically entrapped into nanogels. Heterogeneous colloidal systems are 
responsible for the activation of polymerisation. Emulsion polymerisation and ATRP are used for the 
preparation of biodegradable nanogel. Disulphide-linked bi-functional monomers are used in the 
stimulation of polymerisation. Protein nanogel hybrids using ATRP in water/oil mini emulsions or inverse 
mini-emulsion are useful for the entrapment of covalently bonded proteins into nanogel. In the inverse 
mini-emulsion, a co-initiator was used to initiate the polymerisation of monomers which are firmly 
dispersed in the system [48-49]. 
Drug release mechanism of nanogel 
pH-responsive mechanism  
pH-responsive, nanosized nanogels have received significant attention because of their biological 
relevance and due to their potential applications in drug delivery systems. Drug release is affected by the 
different pH values throughout the human body physiological conditions. pH-responsive block copolymer 
micelles are suitable for controlled delivery applications. In such applications, however, the polymer 
micelles may experience dilutions below the critical micelle concentration (cmc), leading to dissociation 
into monomers. In contrast, nanogels with a cross-linked structure are robust at a diluted concentration. 
Insoluble 3D structures and staying alive at low pH are the main characteristics of methacrylic acid ethyl 
acrylate. The polymeric chain repulsions begin and lead to the precise release profile in procaine 
hydrochloride due to the cumulative pH ranges of acidic group ionisation. Suitable pH at the site of action 
helps with the diffusion of nanogels. pH-responsive monomers play an important role in the preparation of 
nanogels; these are commonly pH-responsive functional groups that deionise in the polymeric assemblies. 
A nanogel containing platinum nanoparticles exhibited on and off catalytic activity for shifting reactive 
oxygen types. In the acidic pH of skin, the protonation of pendant amine of cross-linked poly(2-(N,N-
diethylamino) methacrylate) core as well as PEG group in the polymer greatly enhances the solubilisation of 
drug [43,50-51].  
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Thermosensitive and volume transition mechanism 
Variations in the capacity of nanogels according to temperature are known as the volume phase 
transition temperature (VPTT). Polymers become quenched and hydrated when the surrounding medium is 
below the VPTT. A shrunken and hydrated polymer swells and releases the loaded therapeutic agent. 
Thermo-responsive nanogels rupture in cells and the biological environment when they swell and rise in 
volume. N-isopropyl acrylamide synthesised nanogels have thermoresponsive properties. These nanogels 
have important characteristics, such as rapid contraction in gel volume and the efflux of indomethacin due 
to the maintenance of heat beyond the lower critical solution temperature (LCST). The poly(N-
isopropylacrylamide-co-acrylamide)-loaded 5-fluorouracil gel has been tested on rats in ex vivo studies.  
The loading of the therapeutic agent at lower temperatures and the release from nanogels at body 
temperature makes this suitable for drug delivery. Pluronic acid-modified thermoresponsive 
poly(ethyleneimine) nanogels were effectively used as gene delivery systems. Thermoresponsive nanogels 
with PNIPAM have very exciting and promising applications in the biomedical field, such as the treatment of 
certain cancers through hyperthermia. They can be loaded with an anticancer drug and, at the target 
location, by moderately increasing the temperature above the LCST, the nanogel can change with volume 
and the drug release can be increased [52]. 
Photoisomerisation and photochemical internalization  
Stimulation of photosensitiser-loaded nanogels leads to the synthesis of singlet oxygen and reactive 
oxygen species which causes oxidation of cellular compartment walls such as endosomal barrier walls; this 
affects the release of therapeutics into the cytoplasm. An azo dextran nanogel loaded with aspirin showed 
the e-configuration of the azole group rather than the z-configuration at 365 nm; cis-trans isomerisation of 
azobenzene by photo-regulation in an azo-dextran nanogel loaded with aspirin as a model drug exhibited 
that the e-configuration of the azo group leads to a better release profile of the drug than the z-
configuration at 365 nm radiation [12,43,53].  
Miscellaneous examples 
Degradation of disulphide linkages in cross-linked hyaluronic acid nanogels causes the degradation of 
the nanogel assembly due to the action of reducing agents; in this way, doxorubicin is released by the 
simple diffusive process. The size of the nanogel increases and the layer by layer release of an active 
ingredient is possible without a rapid burst of the drug. The release can be sustained by simple diffusion 
and controlled following initial release mediated by a coating with anionic and cationic polyelectrolytes 
[54].  
The application of nanogels 
Nanogel-based drug delivery formulations improve the effectiveness and safety of anti-cancer drugs, 
antifungal drugs, and anti-diabetic drugs, due to their physicochemical properties, as well as improving the 
ease of administration, as confirmed by in vivo studies. Nanogels have minimum toxicity to nearby tissues 
and high healing effects in cancer treatment at the site of action [55].  
Transdermal drug delivery of an antipyretic drug  
The nanosized dispersion of aceclofenac was formulated by emulsion-solvent diffusion methods and 
then incorporated into a Carbopol 940. The formulation showed optimal permeability properties and 
stability, and achieved a sustained drug release. A nanogel formulation containing diclofenac sodium was 
prepared by the emulsion-solvent diffusion method and then incorporated into a Carbopol 940 [56].  
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Ophthalmic applications 
Curcumin-loaded cationic nanostructured lipid carriers (CNLC) were prepared by film-ultrasonic 
techniques and thermosensitive gelling agents were used to improve pre-ocular retention and the ocular 
permeation capacity of curcumin. Muscone has maximum drug loading in the hydrogel, and the rheology 
results showed that the phase transition temperature was 34°C. Blinking of eyes was resisted due to the 
thixotropy; the recovery time indicated that hydrogel was effective [43,57]. 
Diabetic applications  
In diabetic patients, insulin is injected into muscles every day, which is a very painful process. To 
overcome this problem Lee et al. (2012) developed a chitosan-loaded inhalable deoxycholic acid altered 
glycol chitosan (DOCA-GC) nanogel. Nanogels are self-assembled due to hydrophobic attractions with 
deoxycholic acid; these nanogels formed constant hypoglycaemia over a period of 2 days comparatively at 
the low dose [58]. 
Carrier for antifungal agents  
In fungal infections, physicians and patients prefer the transdermal route. A fluconazole-chitin nanogel 
was formulated by using regeneration chemistry and the wet milling method. Chitin nanogels were 
redeveloped from chitin solution. Fluconazole-chitin has a controlled release pattern which is perfect for 
the continuous availability of fluconazole over a longer period for effective fungal treatment [59]. The 
synthesis of a vitamin E nanoemulsion-based nanogel consisting of the high molecular weight active agent 
amphotericin B has been effectively used for cutaneous fungal infections; the nanogel showed a nearly 4-
fold higher skin deposition through porcine ear skin [60].  
Nanogels in diagnostics and imaging  
Nanogels have properties like structural flexibility, high water content, fluid-like transport, 
biodegradability, and biocompatibility. Gadolinium-assembled nanogels were synthesised by the cross-
linking of branched polyethyleneimines with gadolinium ions. Inverse microemulsion followed by surface-
functionalisation with polyethylene glycol chains was performed to increase the blood circulation time [61]. 
Properties of nanogels 
High water content/swellability  
Nanogels have rapid swelling and de-swelling properties. Water-soluble nanogels show the benefits of 
hydrogels with certain advantages that are necessary for their nanoscale size. Like microgels, nanogels can 
contain and protect drugs and regulate their release by integrating high-affinity functional groups 
containing polymers [43,62].  
Softness  
The softness of nanogels is a very important parameter in the biomedical field and alters their 
biodistribution properties. Softness can be adjusted by changing the chemical structure of the nanogel [63].  
Colloidal stability  
The surface charge of polymers inhibits the development of aggregates in the bloodstream, along with 
their associated problems. This can be altered by increasing the zeta potential that results in higher 
repulsive forces between particles which electrostatically stabilise nanogels. Another method includes the 
integration of surfactants like polyethylene glycol which produce a steric effect and hydration forces to give 
a stable nanosuspension [43,64].  
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Biocompatibility and degradability  
Natural or synthetic polymers are used to synthesise nanogels. These are biocompatible and 
biodegradable, thereby preventing their accumulation in the systemic circulation. Chitosan, poly-acrylic 
acid, methyl cellulose, sodium alginate, and several polysaccharide-based polymers like dextran, pullulan, 
and cyclodextrin can be used to formulate  nanogels. Polysaccharides are typically carbohydrate-based 
polymers formed of repeating monosaccharide units linked by glycosidic bonds. These polymers are stable, 
non-toxic, hydrophilic and biodegradable in nature [65]. 
 Particle size  
Nanogels are able to diffuse through the skin, tissues or compromised areas of the endothelium and in 
some cases through a specific transport system. Some routes of administration face the challenge of 
crossing the blood-brain barrier (BBB) due to their particle size. So, to overcome this issue, nanogels were 
developed which have a size in the diameter range from 20-200 nm. Nanogels have smaller sizes, so cross 
the BBB while inhibiting rapid clearance mechanisms at the same time [43,66]. 
Concluding Remarks 
Nanogels are advanced pharmaceutical nanocarriers for pharmaceutical agents as well as therapeutic 
agents. Nanogel systems could be easily prepared with biomacromolecules with the maximum entrapment 
ability and stability of the resulting formulation in dispersion. Nanogel systems control pharmaceutically-
active compounds with different drug structures. Biopolymers and low molecular mass hydrophobes can 
also be encapsulated in nanogels. The discovery of a new polymeric system is very important for the 
development of nanogels. Advanced polymerisation or cross-linking approaches have a promising role in 
therapies. This is a new approach in the synthesis of nanogel assemblies. Hence, we can expect that these 
advanced nanocarrier systems will be focused upon in future pharmaceutical developments. 
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